Your browser doesn't support javascript.
loading
Dynamin-related protein 1 inhibition reduces hepatic PCSK9 secretion.
Rogers, Maximillian A; Hutcheson, Joshua D; Okui, Takehito; Goettsch, Claudia; Singh, Sasha A; Halu, Arda; Schlotter, Florian; Higashi, Hideyuki; Wang, Lixiang; Whelan, Mary C; Mlynarchik, Andrew K; Daugherty, Alan; Nomura, Masatoshi; Aikawa, Masanori; Aikawa, Elena.
Afiliación
  • Rogers MA; Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Hutcheson JD; Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Okui T; Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Goettsch C; Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Singh SA; Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Halu A; Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Schlotter F; Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Higashi H; Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Wang L; Department of Medical Biochemistry, Kurume University School of Medicine, Kurume 830-0011, Japan.
  • Whelan MC; Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Mlynarchik AK; Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Daugherty A; Saha Cardiovascular Research Center and Department of Physiology, University of Kentucky, Lexington, KY 40536, USA.
  • Nomura M; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.
  • Aikawa M; Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Aikawa E; Center for Excellence in Vascular Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Cardiovasc Res ; 117(11): 2340-2353, 2021 09 28.
Article en En | MEDLINE | ID: mdl-33523181
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mitocondrias Hepáticas / Dinaminas / Retículo Endoplásmico / Aterosclerosis / Quinazolinonas / Proproteína Convertasa 9 / Inhibidores de PCSK9 / Hígado Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Cardiovasc Res Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mitocondrias Hepáticas / Dinaminas / Retículo Endoplásmico / Aterosclerosis / Quinazolinonas / Proproteína Convertasa 9 / Inhibidores de PCSK9 / Hígado Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Cardiovasc Res Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos